Source: International Congress 2016 – Cystic fibrosis: various aspects
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Aduragbemi Faniyi (Belfast, United Kingdom), Aduragbemi Faniyi, Alice Dubois, Michael Tunney, Rebecca Ingram. Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo. Eur Respir J 2016; 48: Suppl. 60, 1264

Member's Comments

No comment yet.

Related content which might interest you: The ancient rubredoxin system: An efficient defense mechanism of pseudomonas aeruginosa during infections Source: International Congress 2014 – Immunology of respiratory infections Year: 2014 Klebsiella respiratory infection community acquired Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Multiresistant bacterial infections Source: School Course 2012 - Lung Transplantation Year: 2012 Molecular mechanisms and virulence of colistin-resistant klebsiella pneumoniae Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Pseudomonas aeruginosa pneumonia in the community Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Monitoring of antimicrobial resistance respiratory strains of streptococcus pneumoniae Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Macrolide-resistant mycoplasma pneumoniae in respiratory tract infection and its clinical relevance Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Clinical implications of agr operon activity in staphylococcus aureus strains isolated from respiratory samples Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015 Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Bacterial infections Source: ERS Course 2016 Year: 2016 Pseudomonas, enterobacteriaceae ESBL positive and staphylococcus MRSA: When to suspect them in CAP? Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Asthma and Atypical Bacterial Infections: Chlamydia pneumonia, Mycoplasma pneumonia and Legionella pneumophila Source: Eur Respir J 2002; 20: Suppl. 38, 427s Year: 2002 Resistance of respiratory tract Streptococcus pneumoniae strains Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002 A staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Monitoring opportunistic microflora in patients with HIV infection and highlighting the significance of Streptococcus gr. viridans in the development of lower respiratory tract infections Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 Pulmonary infections with pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 642s Year: 2004 Aminoglycoside use for pseudomonas aeruginosa in bronchiectasis Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014